We recognize that different expertise is needed to address different diseases. Our model development work is done in collaboration with experts in the field—pharmaceutical, biotech, academic and foundation partners—to make sure we are collectively getting the most out of the models available. By tapping into the breadth of our own scientific staff and engaging experts from around the world, we are able to make resources for disease research available as quickly as possible.
Accessibility to mouse models for preclinical testing is crucial to accelerate the drug-discovery process. Our goal is to promote the rapid distribution and availability of models to researchers around the globe.